Received Aug 27, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HPV9 | HPV (GARDASIL 9) | MERCK & CO. INC. | UNK | — | — |
patient received a dose of GARDASIL 9 on 5/15/2025 and is in the pharmacy to receive the another dose today/pharmacist mentioned that patient might have already received unspecified number of doses outside of recommended schedule in the past; No additional AEs were reported; This spontaneous report was received from a pharmacist concerning a patient of unspecified age and gender. The patient's medical history, concurrent conditions, concomitant therapies and drug reactions/allergies were not reported. On 15-May-2025, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (GARDASIL 9), 1 dosage form (dosage regimen, anatomical location, route of administration, batch/lot # and expiration date were not reported) administered as prophylaxis. It was reported that on 08-Aug-2025 (reported as "today"), the patient was in the pharmacy to receive another dose. The pharmacist mentioned that this patient might have already received unspecified number of doses outside of recommended schedule in the past (inappropriate schedule of product administration). The pharmacist did not have the detailed vaccination record for this patient. No additional adverse events (AEs) were reported (no adverse event). No further information was provided. Batch/lot# is being requested and will be submitted if received.